World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
62
Citations
22554
World Ranking
10542
National Ranking
803

Overview

Angelo Paradiso is affiliated with the National Cancer Research Institute, UK in the United Kingdom. Their research encompasses a broad spectrum of topics within medicine and biochemistry, genetics, and molecular biology, with a particular focus on oncology and molecular biology subfields.

The scientist has contributed extensively to fields such as oncology, molecular biology, genetics, infectious diseases, and reproductive medicine. Major research topics include ovarian cancer diagnosis and treatment, BRCA gene mutations in cancer, reproductive biology and fertility, as well as COVID-19 clinical and related research studies. Additional areas of study involve radiomics and machine learning in medical imaging and cancer genomics and diagnostics.

Paradiso's frequent coauthors include Nicola Silvestris, Erica Silvestris, Miriam Dellino, Giuseppe De Palma, and Simona De Summa, indicating active collaboration within these research networks.

Regarding publication venues, Paradiso often publishes in journals such as Cancers, International Journal of Molecular Sciences, Medicine, Frontiers in Oncology, and Cancer Genomics & Proteomics. These venues reflect a focus on cancer research, molecular sciences, and clinical oncology.

Their notable recent papers include:

  • Basic principles of biobanking: from biological samples to precision medicine for patients (2021), published in Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma (2022), published in Molecular Cancer
  • Breast cancer: an update on treatment-related infertility (2020), published in Journal of Cancer Research and Clinical Oncology
  • Germinal ovarian tumors in reproductive age women (2020), published in Medicine
  • Fertility Preservation in Cancer Patients During the Coronavirus (COVID-19) Pandemic (2020), published in Frontiers in Oncology

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Signatures of mutational processes in human cancer

    Ludmil B. Alexandrov;Serena Nik-Zainal;Serena Nik-Zainal;David C. Wedge;Samuel A. J. R. Aparicio

  • Multicenter Validation of a Gene Expression–Based Prognostic Signature in Lymph Node–Negative Primary Breast Cancer

    John A. Foekens;David Atkins;Yi Zhang;Fred C.G.J. Sweep

  • The complexity of targeting EGFR signalling in cancer: from expression to turnover.

    Sinto Sebastian;Jeffrey Settleman;Stephan J. Reshkin;Amalia Azzariti

  • The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin--one single nature.

    Salvador Harguindey;Gorka Orive;José Luis Pedraz;Angelo Paradiso

  • NHE1 promotes invadopodial ECM proteolysis through acidification of the peri-invadopodial space.

    Giovanni Busco;Rosa A. Cardone;Maria R. Greco;Antonia Bellizzi

  • Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients

    A Paradiso;G Simone;S Petroni;B Leone

  • Cytoskeleton and paclitaxel sensitivity in breast cancer: The role of β-tubulins

    Stefania Tommasi;Anita Mangia;Rosanna Lacalamita;Antonia Bellizzi

  • Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer.

    Angelo Paradiso;A. Mangia;A. Chiriatti;S. Tommasi

  • The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy

    Yi Zhang;Anieta M. Sieuwerts;Michelle McGreevy;Graham Casey

  • Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors.

    Paola Parrella;Maria Luana Poeta;Antonietta Pia Gallo;Maria Prencipe

  • Phosphoinositide 3-Kinase Is Involved in the Tumor-specific Activation of Human Breast Cancer Cell Na+/H+Exchange, Motility, and Invasion Induced by Serum Deprivation

    Stephan J. Reshkin;Antonia Bellizzi;Valentina Albarani;Lorenzo Guerra

  • Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer.

    Rosa Divella;Antonio Mazzocca;Antonella Daniele;Carlo Sabbà

  • The NHERF1 PDZ2 Domain Regulates PKA–RhoA–p38-mediated NHE1 Activation and Invasion in Breast Tumor Cells

    Rosa A. Cardone;Antonia Bellizzi;Giovanni Busco;Edward J. Weinman;Edward J. Weinman

  • DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group.

    Sabine Maier;Inko Nimmrich;Thomas Koenig;Serenella Eppenberger-Castori

  • Basic principles of biobanking: from biological samples to precision medicine for patients.

    Laura Annaratone;Giuseppe De Palma;Giuseppina Bonizzi;Anna Sapino

  • Multicenter Study Using Paraffin-Embedded Tumor Tissue Testing PITX2 DNA Methylation As a Marker for Outcome Prediction in Tamoxifen-Treated, Node-Negative Breast Cancer Patients

    Nadia Harbeck;Inko Nimmrich;Arndt Hartmann;Jeffrey S. Ross

  • Paclitaxel induces apoptosis via protein kinase A- and p38 mitogen-activated protein-dependent inhibition of the Na+/H+ exchanger (NHE) NHE isoform 1 in human breast cancer cells.

    Stephan J. Reshkin;Antonia Bellizzi;Rosa Angela Cardone;Massimo Tommasino

  • A strengthening the reporting of observational studies in epidemiology (STROBE): Are HE4 and CA 125 suitable to detect a Paget disease of the vulva?

    Miriam Dellino;Giulio Gargano;Raffele Tinelli;Carmine Carriero

  • The 76-Gene Signature Defines High-Risk Patients That Benefit from Adjuvant Tamoxifen Therapy.

    Y. Zhang;A. Sieuwerts;M. McGreevy;C. Graham

Frequent Co-Authors

Nicola Silvestris
Nicola Silvestris University of Messina
Jianming Xu
Jianming Xu Zhejiang University
Dino Amadori
Dino Amadori University of Bologna
Gianluigi Giannelli
Gianluigi Giannelli Gastroenterology Hospital "Saverio de Bellis"
John A. Foekens
John A. Foekens Erasmus University Rotterdam
Maria Grazia Daidone
Maria Grazia Daidone University of Milan
Vito Michele Fazio
Vito Michele Fazio Università Campus Bio-Medico
Ioana Berindan-Neagoe
Ioana Berindan-Neagoe Iuliu Hațieganu University of Medicine and Pharmacy
Gennaro Ciliberto
Gennaro Ciliberto Magna Graecia University
Massimo Tommasino
Massimo Tommasino International Agency For Research On Cancer

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in studying Biology or Biochemistry, there are many rewarding career and education options. One path to consider is combining science with management by exploring online healthcare mba programs, which can help you move into administrative or leadership roles in hospitals and labs.

Alternatively, the healthcare industry offers specialized certifications that can lead to well-paying jobs outside of traditional lab work. Understanding the differences between ccs vs cpc credentials is important if you're considering a coding or billing pathway, as each certification comes with unique requirements, costs, and career prospects.

As a certified medical coder salary can vary depending on experience, certification, and job location, but it remains a growth area in healthcare with reliable demand. Before committing, it's valuable to look at the medical coding job outlook to weigh the pros and cons. Exploring these related online degrees and career paths can help you find the best fit for your science-based interests and goals.

Best Scientists Citing Angelo Paradiso

Trending Scientists